Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia
Open Access
- 1 March 2016
- journal article
- Published by Elsevier in Psychosomatics
- Vol. 57 (2) , 208-216
Abstract
No abstract availableKeywords
Funding Information
- Eli Lilly and Company, Indianapolis, IN
This publication has 34 references indexed in Scilit:
- Disclosing a dementia diagnosis: what do patients and family consider important?International Psychogeriatrics, 2014
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyThe Lancet Neurology, 2013
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersThe Lancet Neurology, 2013
- Pathways to diagnosis: exploring the experiences of problem recognition and obtaining a dementia diagnosis among Anglo-CanadiansHealth & Social Care in the Community, 2011
- Missed and Delayed Diagnosis of Dementia in Primary CareAlzheimer Disease & Associated Disorders, 2009
- The pathway to dementia diagnosisMedical Journal of Australia, 2008
- Accuracy of clinical criteria for AD in the Honolulu–Asia Aging Study, a population-based studyNeurology, 2001
- Accuracy of Clinical Operational Diagnostic Criteria for Alzheimer’s Disease in Relation to Different Pathological Diagnostic ProtocolsDementia and Geriatric Cognitive Disorders, 1998
- Diagnosis of Alzheimerʼs Disease in a Community Hospital-Based Brain Bank ProgramSouthern Medical Journal, 1997
- Accuracy of Clinical Diagnosis of Alzheimer Disease and Clinical Features of Patients with Non-Alzheimer Disease NeuropathologyAlzheimer Disease & Associated Disorders, 1996